Salzberger, T.
Typically, the psychometric scale validation is based on various statistical (i.e., quantitative) methods on the one hand and content-related, usually qualitative, considerations on the other. Both approaches are essential but not linked. While statistical relationships between scores determine whether items behave as expected, it is content validity that ultimately provides evidence that we are measuring what we claim to be measuring (i.e., risk perceptions). A measurement mechanism for perceived risk aims at linking qualitative evidence and content validity by specifying an explanatory model of risk. Risk is generally defined as a function of the probability of an outcome and its utility, which is typically negative.
It can be shown that perceptions of probability and negative utility of the health conditions included in the 9-item Perceived Health Risk scale short form of the ABOUT™—Perceived Risk significantly explain psychometric properties of the items and the participants’ level of perceived risk. This not only strengthens the validity of the scale by providing evidence that the ABOUT™—Perceived Risk actually measures perceived risk. It also allows insight into how probability and negative utility contribute to the perceived risk of individual health conditions.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.